Our journey began at Nationwide Children's Hospital, leading to the discovery of the first FDA-approved systemic gene therapy. Today, we stand ready as your reliable partner, equipped with the expertise and scalable solutions to bring your therapies from concept to commercialization. Get in touch and discover how we can contribute to your long-term success with a low risk feasibility study: https://buff.ly/3UzqzNP #andelynbiosciences
Andelyn Biosciences’ Post
More Relevant Posts
-
There are many obstacles with managing the ancillary materials used in the production of cell and gene therapy products. In this webinar, sponsored by BioLegend, we discover the critical qualities of cytokines, growth factors, antibodies and culture media and risk-based strategies for assessing these challenges. Register now >>> https://hubs.ly/Q02HD5hk0
To view or add a comment, sign in
-
The supply chain for cell and gene therapies is complex and requires next-level precision and oversight. Learn more about what you can do to bridge the gap between manufacturing and delivery of the finished therapy to the patient. https://ow.ly/F8Ki50S90rl
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Business Development Manager | Progressing your drug development journey - Toxicology, Pharmacology, DMPK, IND Enabling Packages, Supporting Western US
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
The supply chain for cell and gene therapies is complex and requires next-level precision and oversight. Learn more about what you can do to bridge the gap between manufacturing and delivery of the finished therapy to the patient. https://ow.ly/F8Ki50S90rl
To view or add a comment, sign in
-
The supply chain for cell and gene therapies is complex and requires next-level precision and oversight. Learn more about what you can do to bridge the gap between manufacturing and delivery of the finished therapy to the patient. https://ow.ly/F8Ki50S90rl
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
The supply chain for cell and gene therapies is complex and requires next-level precision and oversight. Learn more about what you can do to bridge the gap between manufacturing and delivery of the finished therapy to the patient. https://ow.ly/F8Ki50S90rl
To view or add a comment, sign in
7,798 followers